Cargando…

Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs

The ability to support a comprehensive vaccine research and development (R&D) portfolio from a health security perspective has taken on enhanced significance over the past 3 years whereby countries that had existing vaccine R&D infrastructure (G7, Russia and China) have been at the forefront...

Descripción completa

Detalles Bibliográficos
Autores principales: Hare, Jonathan, Riggall, Giovanna, Bongers, Alexander, Ramesh, Kirthi, Kokareva, Larissa, Chin, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017735/
https://www.ncbi.nlm.nih.gov/pubmed/36935694
http://dx.doi.org/10.3389/fpubh.2023.1143790
_version_ 1784907655176781824
author Hare, Jonathan
Riggall, Giovanna
Bongers, Alexander
Ramesh, Kirthi
Kokareva, Larissa
Chin, Brian
author_facet Hare, Jonathan
Riggall, Giovanna
Bongers, Alexander
Ramesh, Kirthi
Kokareva, Larissa
Chin, Brian
author_sort Hare, Jonathan
collection PubMed
description The ability to support a comprehensive vaccine research and development (R&D) portfolio from a health security perspective has taken on enhanced significance over the past 3 years whereby countries that had existing vaccine R&D infrastructure (G7, Russia and China) have been at the forefront of global efforts to combat COVID-19. Few countries outside of these key players have the infrastructure necessary to develop national vaccine programs, though this is beginning to change with investment across many low- and middle-income countries. These same opportunities exist for countries in Central and West Asia, and in this perspective, we highlight the existing infrastructure and expertise across seven countries (Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Tajikistan, and Uzbekistan) and propose opportunities for enhanced collaboration along with a bold proposal for establishing a new-build, regional vaccine translational research institute to facilitate the development of a robust, regional vaccine R&D environment to combat existing and future health challenges.
format Online
Article
Text
id pubmed-10017735
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100177352023-03-17 Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs Hare, Jonathan Riggall, Giovanna Bongers, Alexander Ramesh, Kirthi Kokareva, Larissa Chin, Brian Front Public Health Public Health The ability to support a comprehensive vaccine research and development (R&D) portfolio from a health security perspective has taken on enhanced significance over the past 3 years whereby countries that had existing vaccine R&D infrastructure (G7, Russia and China) have been at the forefront of global efforts to combat COVID-19. Few countries outside of these key players have the infrastructure necessary to develop national vaccine programs, though this is beginning to change with investment across many low- and middle-income countries. These same opportunities exist for countries in Central and West Asia, and in this perspective, we highlight the existing infrastructure and expertise across seven countries (Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Tajikistan, and Uzbekistan) and propose opportunities for enhanced collaboration along with a bold proposal for establishing a new-build, regional vaccine translational research institute to facilitate the development of a robust, regional vaccine R&D environment to combat existing and future health challenges. Frontiers Media S.A. 2023-03-02 /pmc/articles/PMC10017735/ /pubmed/36935694 http://dx.doi.org/10.3389/fpubh.2023.1143790 Text en Copyright © 2023 Hare, Riggall, Bongers, Ramesh, Kokareva and Chin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Hare, Jonathan
Riggall, Giovanna
Bongers, Alexander
Ramesh, Kirthi
Kokareva, Larissa
Chin, Brian
Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs
title Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs
title_full Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs
title_fullStr Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs
title_full_unstemmed Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs
title_short Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs
title_sort vaccine research and development capacity in central and west asia: a path toward sustainable vaccine r&d programs
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017735/
https://www.ncbi.nlm.nih.gov/pubmed/36935694
http://dx.doi.org/10.3389/fpubh.2023.1143790
work_keys_str_mv AT harejonathan vaccineresearchanddevelopmentcapacityincentralandwestasiaapathtowardsustainablevaccinerdprograms
AT riggallgiovanna vaccineresearchanddevelopmentcapacityincentralandwestasiaapathtowardsustainablevaccinerdprograms
AT bongersalexander vaccineresearchanddevelopmentcapacityincentralandwestasiaapathtowardsustainablevaccinerdprograms
AT rameshkirthi vaccineresearchanddevelopmentcapacityincentralandwestasiaapathtowardsustainablevaccinerdprograms
AT kokarevalarissa vaccineresearchanddevelopmentcapacityincentralandwestasiaapathtowardsustainablevaccinerdprograms
AT chinbrian vaccineresearchanddevelopmentcapacityincentralandwestasiaapathtowardsustainablevaccinerdprograms